1. Home
  2. GANX vs CMCM Comparison

GANX vs CMCM Comparison

Compare GANX & CMCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.70

Market Cap

74.6M

Sector

Health Care

ML Signal

HOLD

Logo Cheetah Mobile Inc. each representing fifty (50)

CMCM

Cheetah Mobile Inc. each representing fifty (50)

HOLD

Current Price

$2.89

Market Cap

88.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GANX
CMCM
Founded
2017
2009
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
74.6M
88.8M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
GANX
CMCM
Price
$1.70
$2.89
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.50
N/A
AVG Volume (30 Days)
629.3K
5.7K
Earning Date
05-13-2026
06-18-2026
Dividend Yield
N/A
N/A
EPS Growth
31.46
N/A
EPS
N/A
N/A
Revenue
$55,180.00
N/A
Revenue This Year
N/A
$11.61
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$2.65
52 Week High
$4.34
$9.44

Technical Indicators

Market Signals
Indicator
GANX
CMCM
Relative Strength Index (RSI) 45.61 34.37
Support Level $1.65 $2.65
Resistance Level $2.15 $7.15
Average True Range (ATR) 0.12 0.10
MACD -0.00 0.03
Stochastic Oscillator 36.60 33.14

Price Performance

Historical Comparison
GANX
CMCM

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

About CMCM Cheetah Mobile Inc. each representing fifty (50)

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The companies products and services includes Robotic Products, Global to B Services etc. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC.

Share on Social Networks: